NCT02673931View on ClinicalTrials.gov

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,400

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Coronary DiseaseShock, CardiogenicRenal FailureStrokeBrain InjuryAortic Valve Disease
Interventions
DRUG

Byetta (Lilly, Exenatide)

See description of arms

DRUG

Conoxia (AGA, oxygen)

See description arms

DRUG

20% Human Albumin

Trial Locations (1)

2100

Rigshospitalet - Copenhagen University Hospital, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02673931 - GLP-1 and Hyperoxia for Organ Protection in Heart Surgery | Biotech Hunter | Biotech Hunter